Page last updated: 2024-09-02

hydroxybenzylpindolol and methylprednisolone

hydroxybenzylpindolol has been researched along with methylprednisolone in 1 studies

Compound Research Comparison

Studies
(hydroxybenzylpindolol)
Trials
(hydroxybenzylpindolol)
Recent Studies (post-2010)
(hydroxybenzylpindolol)
Studies
(methylprednisolone)
Trials
(methylprednisolone)
Recent Studies (post-2010) (methylprednisolone)
301020,2472,6025,317

Protein Interaction Comparison

ProteinTaxonomyhydroxybenzylpindolol (IC50)methylprednisolone (IC50)
Glucocorticoid receptorHomo sapiens (human)0.011
Glycine receptor subunit alpha-1Rattus norvegicus (Norway rat)0.011
Glycine receptor subunit betaRattus norvegicus (Norway rat)0.011
Glycine receptor subunit alpha-2Rattus norvegicus (Norway rat)0.011
Glycine receptor subunit alpha-3Rattus norvegicus (Norway rat)0.011

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abou-Sayf, FK; Carlsson, C; Carney, E; Cutler, S; Fuse, A; Gallagher, ET; Ogawa, R; Saito, T; Takanashi, M; Yamada, K1

Trials

1 trial(s) available for hydroxybenzylpindolol and methylprednisolone

ArticleYear
The effect of methylprednisolone on myocardial beta-adrenergic receptors and cardiovascular function in shock patients.
    Shock (Augusta, Ga.), 1996, Volume: 5, Issue:4

    Topics: Adult; Blood Pressure; Catecholamines; Female; Heart; Heart Rate; Humans; Male; Methylprednisolone; Middle Aged; Myocardium; Pindolol; Receptors, Adrenergic, beta; Shock; Vascular Resistance

1996